🔥🐔 BizChicken 🐔🔥

Learn About the Corporations Around You

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Esperion Therapeutics, Inc.

Esperion Therapeutics, Inc. logo
Market Cap: Medium
Employees: Low

NEXLETOL and NEXLIZET

Esperion Therapeutics, Inc. is a pharmaceutical company focused on developing and commercializing medicines for treating elevated low density lipoprotein cholesterol. Its main products are NEXLETOL and NEXLIZET, aimed at treating conditions like atherosclerotic cardiovascular disease.

Tags: NEXLETOL, NEXLIZET, cardiovascular, cholesterol, medicine, pharmaceutical

Website

About | Leadership | Directors | About | ESG | About | Contact | Careers | About | About | About

Symbol: ESPR

Recent Price: $2.28

Industry: Drug Manufacturers - Specialty & Generic

CEO: Mr. Sheldon L. Koenig

Sector: Healthcare

Employees: 240

Address: 3891 Ranchero Drive, Ann Arbor, MI 48108

Phone: 734 887 3903

Leadership

  • Sheldon Koenig, Chief Executive Officer
  • Glenn Brame, Chief Technical Operations Officer
  • Ben Halladay, Chief Financial Officer, MBA
  • Benjamin O. Looker, General Counsel
  • Betty Jean (BJ) Swartz, Chief Business Officer
  • Eric Warren, R.Ph., Chief Commercial Officer
  • J. Martin Carroll, Chairman of the Board
  • Seth H.Z. Fischer, Member of the Compliance Committee Chair of the Compensation Committee
  • Alan Fuhrman, Chief Financial Officer
  • Antonio Gotto, Jr., MD, DPhil, Member of the Nominating and Governance Committee
  • Stephen Rocamboli, Chief Executive Officer of Innovatrx, Inc.
  • Jay Shepard, Venture Partner with Catalys Pacific
  • Nicole Vitullo, Lead Independent Director
  • Tracy Woody, Member of the Nominating and Governance Committee Chair of the Compliance Committee

Last updated: 2024-11-08